Name | Title | Contact Details |
---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
A-Dec, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Newberg, OR. To find more information about A-Dec, Inc., please visit www.a-dec.com
Chrysalis Health is proud to be one of the leading providers of behavioral healthcare services for children, adolescents, adults, and families throughout Florida.
Dedicated Clinical Research II-IV is a Litchfield Park, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Innovation and quality are traditions that have kept Pelton and Crane at the forefront of the dental industry for over 108 years. Pelton and Crane was founded by Dr. R.M. Pelton, a dentist who felt the need in his own practice for a furnace used to bake